Summary: With double-digit increases looming for most Part D premiums, Morningstar columnist Mark Miller urges seniors to examine their options to ensure they are in the optimal drug plan for 2013.
Summary: With double-digit increases looming for most Part D premiums, Morningstar columnist Mark Miller urges seniors to examine their options to ensure they are in the optimal drug plan for 2013.